Table 1.
Patient characteristics pre-transplant
| Characteristic | N (%) or median (range) |
|---|---|
| Patient Age | 37 (19–50) |
| Patient Sex | |
| Female | 15 (50%) |
| Male | 15 (50%) |
| Disease Status at Transplant | |
| AML (including 2 MDS) | 24 (80%) |
| CR1 | 6 (20%) |
| R1 | 6 (20%) |
| IF | 10 (33%) |
| untreated RAEB-t | 2 (6%) |
| ALL | 6 (20%) |
| R1 | 1 (3%) |
| R2 | 1 (3%) |
| IF | 4 (13%) |
| Cytogenetics | |
| Indeterminate* | 1 (3%) |
| Intermediate | 14 (47%) |
| Unfavorable | 15 (50%) |
| Stem Cell source | |
| Bone Marrow | 1 (3%) |
| Peripheral Blood | 29 (97%) |
| For patients with active disease | |
| WBC pre-conditioning | 3.4 (0.9–29.2) |
| % blasts in bone marrow | 16.5 (0–95) |
| % blasts in peripheral blood | 3.5 (0–92) |
*
Cytogenetic risk is classified as indeterminate by Pullarkat et al. 2008 [9]. CR1 = 1st complete remission, R1 = 1st relapse, R2 = 2nd relapse, IF = induction failure, WBC = white blood cell count